Regulus Therapeutics Inc. (RGLS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 10:04AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 131.59M |
| Enterprise value | 35.45M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 1.22 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 0.57 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.59 |
| 52-week change 3 | 46.72% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 3.7900 |
| 52-week low 3 | 1.0800 |
| 50-day moving average 3 | 2.4256 |
| 200-day moving average 3 | 1.6429 |
Share statistics
| Avg vol (3-month) 3 | 3.23M |
| Avg vol (10-day) 3 | 486.44k |
| Shares outstanding 5 | 65.47M |
| Implied shares outstanding 6 | 65.47M |
| Float 8 | 41.55M |
| % held by insiders 1 | 1.68% |
| % held by institutions 1 | 80.23% |
| Shares short (30 Apr 2024) 4 | 4.21M |
| Short ratio (30 Apr 2024) 4 | 13.91 |
| Short % of float (30 Apr 2024) 4 | 8.17% |
| Short % of shares outstanding (30 Apr 2024) 4 | 6.43% |
| Shares short (prior month 28 Mar 2024) 4 | 5.42M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 04 Oct 2018 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 29 Jun 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -50.20% |
| Return on equity (ttm) | -110.27% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -30.88M |
| Net income avi to common (ttm) | -30.04M |
| Diluted EPS (ttm) | -1.5800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 23.77M |
| Total cash per share (mrq) | 0.36 |
| Total debt (mrq) | 3.1M |
| Total debt/equity (mrq) | 14.64% |
| Current ratio (mrq) | 3.31 |
| Book value per share (mrq) | 1.05 |
Cash flow statement
| Operating cash flow (ttm) | -26.77M |
| Levered free cash flow (ttm) | -16.93M |
© 2024 Yahoo. All rights reserved.